Haleon
NYSE: HLN
$9.80 ▲ +0.09  (+0.88%)
At close: Jul 24, 2026 · 3:59 PM UTC
Financial Ratios
Market Cap88.07 Bn
P/E103.29
P/S6.00
Div. Yield0.00
Total Debt (Qtr)11.45 Bn
Add ratio to table…

About

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic CIK: 0001900304

Products and services [axis] Breakdown of Revenue (2025)

Markets of customers [axis] Breakdown of Revenue (2025)

Peer Comparison

Companies in the Drug Manufacturers - Specialty & Generic
S.No. Ticker Company Market CapP/EP/STotal Debt (Qtr)
1 HLN Haleon plc 88.07 Bn103.296.0011.45 Bn
2 TEVA Teva Pharmaceutical Industries Ltd 35.75 Bn23.022.0616.63 Bn
3 ZTS Zoetis Inc. 31.84 Bn12.053.359.05 Bn
4 TAK Takeda Pharmaceutical Co Ltd 27.18 Bn-10.290.5928.76 Bn
5 UTHR UNITED THERAPEUTICS Corp 23.09 Bn17.937.28-
6 RDHL RedHill Biopharma Ltd. 21.32 Bn2,931.662.24-
7 VTRS Viatris Inc 19.96 Bn-67.321.3714.34 Bn
8 NBIX Neurocrine Biosciences Inc 17.66 Bn26.415.69-